Literature DB >> 9845426

Diagnosis and interpretation of steatosis and steatohepatitis.

A D Burt1, A Mutton, C P Day.   

Abstract

Steatosis--accumulation of triacylglycerol in hepatocytes--is a common finding in liver biopsy specimens. The commonest form is macrovesicular change, which occurs in response to a wide range of insults. In the absence of other features, the pathologist cannot ascertain the likely cause on morphological features alone but can give an indication of the severity of steatosis. Close clinicopathological correlation is required to establish the cause. In most instances, macrovesicular steatosis is at least potentially reversible. Although it may be thought of as a benign condition, it may be associated with the development of necroinflammation and fibrosis--so-called steatohepatitis. The classic example of this is alcoholic hepatitis, but there is increasing awareness of steatohepatitis occurring in nonalcoholics: NASH. Distinction between alcoholic hepatitis and NASH on purely histological grounds may be impossible; careful clinicopathological discussion is mandatory. Microvesicular steatosis is generally a more severe disease than the macrovesicular form and is seen in a variety of conditions in which there is either an inherited or an acquired defect in beta-oxidation of fatty acids; the former includes mitochondrial cytopathies and disorders of ureagenesis, and the latter includes acute fatty liver of pregnancy and Reye's syndrome. This review describes the morphological features of steatosis and steatohepatitis, considers their pathogenesis, and outlines the clinical significance of the different patterns of injury.

Entities:  

Mesh:

Year:  1998        PMID: 9845426

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  52 in total

1.  Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet.

Authors:  Michael K Pickens; Hisanobu Ogata; Russell K Soon; James P Grenert; Jacquelyn J Maher
Journal:  Liver Int       Date:  2010-06-08       Impact factor: 5.828

Review 2.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

3.  Apoptosis in chronic viral hepatitis parallels histological activity: an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody.

Authors:  Jo L McPartland; Muna Ali Guzail; Charles H Kendall; James Howard Pringle
Journal:  Int J Exp Pathol       Date:  2005-02       Impact factor: 1.925

Review 4.  Acute Kidney Injury in Pregnancy.

Authors:  Belinda Jim; Vesna D Garovic
Journal:  Semin Nephrol       Date:  2017-07       Impact factor: 5.299

5.  Schisandra chinensis prevents alcohol-induced fatty liver disease in rats.

Authors:  Hyoung Joon Park; Soo-Jung Lee; Yuno Song; Sun-Hee Jang; Yeoung-Gyu Ko; Suk Nam Kang; Byung Yeoup Chung; Hong-Duck Kim; Gon-Sup Kim; Jae-Hyeon Cho
Journal:  J Med Food       Date:  2014-01       Impact factor: 2.786

6.  Histological Patterns of Hepatitis and Cholangitis.

Authors:  Raouf E Nakhleh
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

7.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

Authors:  I A Leclercq; G C Farrell; J Field; D R Bell; F J Gonzalez; G R Robertson
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

8.  Long term prognosis of fatty liver: risk of chronic liver disease and death.

Authors:  S Dam-Larsen; M Franzmann; I B Andersen; P Christoffersen; L B Jensen; T I A Sørensen; U Becker; F Bendtsen
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using Oil Red O staining.

Authors:  G B Hunt; J A Luff; L Daniel; R Van den Bergh
Journal:  Vet Pathol       Date:  2013-03-25       Impact factor: 2.221

10.  A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH.

Authors:  Fusako Takayama; Toru Egashira; Hiromu Kawasaki; Mitsumasa Mankura; Kazuo Nakamoto; Shigeru Okada; Akitane Mori
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.